Adoptive immunotherapy of EBV-associated malignancies with EBV-specific cytotoxic T-cell lines

Curr Top Microbiol Immunol. 2001:258:221-9. doi: 10.1007/978-3-642-56515-1_14.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Hematopoietic Stem Cell Transplantation / adverse effects
  • Herpesvirus 4, Human / immunology*
  • Herpesvirus 4, Human / pathogenicity
  • Herpesvirus 4, Human / physiology*
  • Hodgkin Disease / immunology
  • Hodgkin Disease / therapy
  • Hodgkin Disease / virology
  • Humans
  • Immunotherapy, Adoptive / adverse effects
  • Immunotherapy, Adoptive / methods*
  • Lymphocyte Activation
  • Lymphoproliferative Disorders / immunology
  • Lymphoproliferative Disorders / therapy*
  • Lymphoproliferative Disorders / virology*
  • T-Lymphocytes, Cytotoxic / immunology*